These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

525 related items for PubMed ID: 18376222

  • 1. Effect of combined therapy using balloon-occluded arterial infusion of cisplatin and hemodialysis with concurrent radiation for locally invasive bladder cancer.
    Azuma H, Kotake Y, Yamamoto K, Sakamoto T, Kiyama S, Ubai T, Inamoto T, Takahara K, Matsuki M, Segawa N, Shibahara N, Katsuoka Y.
    Am J Clin Oncol; 2008 Feb; 31(1):11-21. PubMed ID: 18376222
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A phase I/II trial of transurethral surgery combined with concurrent cisplatin, 5-fluorouracil and twice daily radiation followed by selective bladder preservation in operable patients with muscle invading bladder cancer.
    Zietman AL, Shipley WU, Kaufman DS, Zehr EM, Heney NM, Althausen AF, McGovern FJ.
    J Urol; 1998 Nov; 160(5):1673-7. PubMed ID: 9783929
    [Abstract] [Full Text] [Related]

  • 7. Conservative treatment of invasive bladder carcinoma by transurethral resection, protracted intravenous infusion chemotherapy, and hyperfractionated radiotherapy: long term results.
    Danesi DT, Arcangeli G, Cruciani E, Altavista P, Mecozzi A, Saracino B, Orefici F.
    Cancer; 2004 Dec 01; 101(11):2540-8. PubMed ID: 15481058
    [Abstract] [Full Text] [Related]

  • 8. Intraarterial infusion of cisplatin with and without preoperative concurrent radiation for urinary bladder cancer: a preliminary report.
    Monzen Y, Mori H, Matsumoto S, Takaki H, Yoshida S, Wakisaka M, Ueda S, Mizoguchi H, Ogata J, Kato Y.
    Radiat Med; 1995 Dec 01; 13(3):149-52. PubMed ID: 7569009
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Low-dose chemoradiotherapy followed by partial or radical cystectomy against muscle-invasive bladder cancer: an intent-to-treat survival analysis.
    Koga F, Yoshida S, Kawakami S, Kageyama Y, Yokoyama M, Saito K, Fujii Y, Kobayashi T, Kihara K.
    Urology; 2008 Aug 01; 72(2):384-8. PubMed ID: 18455771
    [Abstract] [Full Text] [Related]

  • 12. Long-term follow up of patients with invasive bladder carcinoma receiving combined cisplatin-based intra-arterial chemotherapy and radiotherapy.
    Mori K, Nomata K, Noguchi M, Eguchi J, Hayashi N, Kanetake H.
    Int J Urol; 2007 Jul 01; 14(7):591-4. PubMed ID: 17645599
    [Abstract] [Full Text] [Related]

  • 13. [Balloon-occluded arterial infusion as chemotherapy in bladder cancer--long-term results].
    Mitsuzane K, Kawabata M, Terada M, Nomura S, Sato M, Yamada R.
    Gan To Kagaku Ryoho; 1990 Aug 01; 17(8 Pt 2):1701-4. PubMed ID: 2117901
    [Abstract] [Full Text] [Related]

  • 14. [Treatment of infiltrating cancer of the bladder with cisplatin, fluorouracil, and concurrent radiotherapy: results of a pilot study].
    Chauvet B, Félix-Faure C, Davin JL, Berger C, Vincent P, Reboul F.
    Cancer Radiother; 1998 Apr 01; 2 Suppl 1():77s-81s. PubMed ID: 9749084
    [Abstract] [Full Text] [Related]

  • 15. Novel bladder preservation therapy for locally invasive bladder cancer: combined therapy using balloon-occluded arterial infusion of anticancer agent and hemodialysis with concurrent radiation.
    Azuma H, Inamoto T, Ibuki N, Ubai T, Kotake Y, Takahara K, Kiyama S, Nomi H, Uehara H, Komura K, Yamamoto K, Narumi Y, Katsuoka Y.
    Int J Oncol; 2010 Oct 01; 37(4):773-85. PubMed ID: 20811698
    [Abstract] [Full Text] [Related]

  • 16. An organ-sparing treatment using combined intra-arterial chemotherapy and radiotherapy for muscle-invading bladder carcinoma.
    Tsukamoto S, Ishikawa S, Tsutsumi M, Nakajima K, Sugahara S.
    Scand J Urol Nephrol; 2002 Oct 01; 36(5):339-43. PubMed ID: 12487737
    [Abstract] [Full Text] [Related]

  • 17. Combined modality treatment with bladder preservation for muscle invasive bladder cancer.
    Sabaa MA, El-Gamal OM, Abo-Elenen M, Khanam A.
    Urol Oncol; 2010 Oct 01; 28(1):14-20. PubMed ID: 18818110
    [Abstract] [Full Text] [Related]

  • 18. Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3-T4) oropharyngeal squamous cell carcinoma.
    Finnegan V, Parsons JT, Greene BD, Sharma V.
    Head Neck; 2009 Feb 01; 31(2):167-74. PubMed ID: 18853443
    [Abstract] [Full Text] [Related]

  • 19. Radiochemotherapy after transurethral resection is an effective treatment method in T1G3 bladder cancer.
    Akçetin Z, Todorov J, Tüzel E, Engehausen DG, Krause FS, Sauer R, Schrott KM, Rödel C.
    Anticancer Res; 2005 Feb 01; 25(3A):1623-8. PubMed ID: 16033071
    [Abstract] [Full Text] [Related]

  • 20. The novel bladder preservation therapy BOAI-CDDP-radiation (OMC-regimen): a new treatment option for invasive bladder cancer patients with lymph node metastasis.
    Azuma H, Inamoto T, Takahara K, Nomi H, Hirano H, Ibuki N, Uehara H, Komura K, Minami K, Uchimoto T, Saito K, Takai T, Tanda N, Yamamoto K, Narumi Y, Kiyama S.
    Int J Oncol; 2014 Jun 01; 44(6):1895-903. PubMed ID: 24728124
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.